Top

CardioVascular and Interventional Radiology

Published in:

01-07-2008 | Review

Endovascular Brachytherapy in the Femoropopliteal Segment Using ¹⁹²Ir and ¹⁸⁸Re

Authors: Walter A. Wohlgemuth, Giesbert Leissner, Hermann Wengenmair, Klaus Bohndorf, Klaus Kirchhof

Published in: CardioVascular and Interventional Radiology | Issue 4/2008

Abstract

This report presents a review of the literature on endovascular brachytherapy (EVBT) after percutaneous transluminal angioplasty (PTA) in the femoropopliteal segment. We summarize the pathophysiological changes induced by PTA and EVBT within the vessel wall, technical considerations regarding various radiation sources and their application, the impact of stents on the radial dose profile, recommendations for dosimetry of beta and gamma sources, results of experimental and clinical trials, and the medication required before, during, and after EVBT. We aim to help to identify patients who are eligible for EVBT, to choose an appropriate technical approach, and to initiate adequate antiplatelet and anticoagulant therapy.

Schopohl B, Liermann D, Pohlit LJ, et al. (1996) ¹⁹²Ir endovascular brachytherapy for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels: 6 years of experience. Int J Radiat Oncol Biol Phys 36:835–840PubMedCrossRef

Block P, Myler R, Stertzer S, et al. (1981) Morphology after transluminal angioplasty in human beings. N Engl J Med 305:382–385PubMedCrossRef

Leu H (1982) Morphology of the arterial wall after percutaneous transluminal dilatation. Vasa 11:265–269PubMed

Ip JH, Fuster V, Badimon L, et al. (1990) Syndromes of acceleration atherosclerosis: role of vascular injury and smooth muscle cell prolifartion. J Am Coll Cardiol 15:1667–1687PubMedCrossRef

Ip JH, Fuster V, Israel D, et al. (1991) The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. Am J Coll Cardiol 17:77B–88BCrossRef

Kockx MM, De Meyer GR, Jacob WA, et al. (1993) Triphasic sequence of neointimal formation in the cuffed carotid artery of the rabbit. Arterioscler Thromb 12:1447–1457

Scott NA, Cipolla GD, Ross CE, et al. (1996) Identification of a potential role of the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93:2178–2187PubMed

Christen T, Verin V, Bochaton-Piallat M, et al. (2001) Mechanisms of neointima formation and remodelling in the porcine coronary artery. Circulation 103:882–888PubMed

Mintz GS, Popma JJ, Hong MK, et al. (1996) Intravascular ultrasound to discern device-specific effects and mechanisms of restenosis. Am J Cardiol 78:18–22PubMedCrossRef

10.

Mintz GS, Popma JJ, Pichard AD, et al. (1996) Arterial remodeling after coronary angioplasty:a serial intravascular ultrasound study. Circuation 94:35–43

11.

Kuntz RE, Gibson CM, Nobuyoshi M, et al. (1993) Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol 21:15–25PubMedCrossRef

12.

Kuntz RE, Safian RD, Levine MJ, et al. (1992) Novel approach to the analysis of restenosis after the use of three new coronary devices. J am Coll Cardiol 19:1493–1499PubMedCrossRef

13.

Schwartz SM, Reidy MA (1996) Restenosis: an assessment of factors important in arterial occlusion. In: Fuster V, Ross R, Topol EJ (eds) Atherosclerosis and coronary artery disease. Lippincott-Raven, Philadelphia, pp 701–714

14.

Schwartz RS, Henry TD (2002) Pathophysiology of coronary artery restenosis. Rev Cardiovasc Med 3(Suppl 5):S4–S9PubMed

15.

Davies MG, Hagen PO (1994) Pathobiology of intimal hyperplasia. Br J Surg 81:1254–1269PubMedCrossRef

16.

Hancock WW, Adams DH, Wyner LR, et al. (1994) CD4+ monolayer cells induce cytokine expression, vascular smooth muscle cell proliferation, and arterial occlusion after endothelial injury. Am J Pathol 145:1008–1014PubMed

17.

Hanke H, Hassenstein S, Ulmer A, et al. (1994) Accumulation of macrophages in the arterial vessel wall following experimental balloon angioplasty. Eur Heart J 15:691–698PubMed

18.

Koyama N, Hart CE, Clowes AW (1994) Different functions of the platelet derived growth factor alpha and beta receptors for the migration and proliferation of cultured baboon smooth muscle cells. Circ Res 75:682–691PubMed

19.

Andersen HR, Maeng M, Thorwest M, et al. (1996) Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury: insights form a porcine coronary (re)stenosis model. Circulation 93:1716–1724PubMed

20.

Isner JM (1994) Vascular remodeling: Honey, I think I shrunk the artery. Circulation 89:2937–2941PubMed

21.

Luo H, Nishioka T, Eigler N, et al. (1996) Coronary artery restenosis after balloon angioplasty in humans is associated with circumferential coronary constriction. Arterioscler Thromb Vasc Biol 16:1393–1398PubMed

22.

Post MJ, Borst C, Pasterkamp G, et al. (1995) Arterial remodeling in atherosclerosis and restenosis: a vague concept of a distinct phenomenon. Atherosclerosis 118(Suppl):115–123CrossRef

23.

Mehran R, Dangas G, Mintz GS, et al. (2000) Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients. Circulation 101:604–610PubMed

24.

Mintz GS, Pichard AD, Kent KM, et al. (1994) Intravascular ultrasound comparison of restenotic and de novo coronary artery narrowings. Am J Cardiol 74:1278–1280PubMedCrossRef

25.

Krueger K, Zaehringer M, Stuetzer H, et al. (2004) De novo femoropopliteal stenoses: endovascular gamma irradiation following angioplasty–angiographic and clinical follow-up in a prospective randomized controlled trial. Radiology 231:546–554PubMedCrossRef

26.

Minar E, Pokrajac B, Maca T, et al. (2000) Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation 102:2694–2699PubMed

27.

Wolfram RM, Budinsky AC, Pokrajac B, et al. (2005) Endovascular brachytherapy: restenosis in de novo versus recurrent lesions of femoropopliteal artery—the Vienna experience. Radiology 236:338–342PubMedCrossRef

28.

Gallino A, Mahler F, Probst P, et al. (1984) Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5 year follow-up. Circulation 70:619–623PubMed

29.

Murray RR Jr, Hewes RC, White RI Jr, et al. (1987) Long-segment femoropopliteal stenoses: Is angioplasty a boon or a bust? Radiology 162:473–476PubMed

30.

Krepel VM, van Andel GJ, van Erp WF, et al. (1985) Percutaneous transluminal angioplasty of the femoropoliteal artery: initial and long-term results. Radiology 156:325–328PubMed

31.

Capek P, McLean GK, Berkowitz HD (1991) Femoropopliteal angioplasty. Factors influencing long-term success. Circulation 83:I70–I80PubMed

32.

Johnston KW (1992) Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology 183:767–771PubMed

33.

Matsi PJ, Manninen HI, Vanninen RL, et al. (1994) Femoropopliteal angioplasty in patients with claudication:primary and secondary patency in 140 limbs with 1–3-year follow-up. Radiology 191:727–733PubMed

34.

Wolfram RM, Budinsky AC, Pokrajac B, et al. (2006) Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: five-year follow-up—prospective randomized study. Radiology 240:878–884PubMedCrossRef

35.

van Tongeren RB, van Sambeek MRHM, van Overhagen H, et al. (2005) Endovascular brachytherapy for the prevention of restenosis after femoropopliteal angioplasty. Results of the VARA Trial. J Cardiovasc Surg 46:437–443

36.

Muradin GS, Bosch JL, Stijnen T, et al. (2001) Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease. Radiology 221:137–145PubMedCrossRef

37.

Vroegindeweij D, Vos LD, Tielbeek AV, et al. (1997) Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. CardioVasc Interv Radiol 20:420–425CrossRef

38.

Grimm J, Müller-Hülsbeck S, Jahnke T, et al. (2001) Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol 12:935–942PubMedCrossRef

39.

Cejna M, Thurnher S, Illiasch H, et al. (2001) PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol 12:23–31PubMedCrossRef

40.

Zdanowski Z, Albrechtsson U, Lundin A, et al. (1999) Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study. Int Angiol 18:251–255PubMed

41.

Schillinger M, Sabeti S, Loewe C, et al. (2006) Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354:1879–1888PubMedCrossRef

42.

Wissgott C, Steinkamp H (2007) Primäres Stenting vs. PTA in der AFS: Ergebnisse der FAST-Studie. Fortschr Röntgenstr 179:S243

43.

Dormandy JA, Rutherford RB (2000) Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31:S1–S296PubMedCrossRef

44.

Minar E, Ahmadi A, Koppensteiner R, et al. (1995) Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty. Circulation 91:2167–2173PubMed

45.

Pukac LA, Hirsch GM, Lormeau JC, et al. (1991) Antiproliferative effects of novel, nonanticoagulant heparin derivates on vascular smooth muscle cells in vitro and in vivo. Am J Pathol 139:1501–1509PubMed

46.

Gallino A, Do D-D, Alerci M, et al. (2004) Effects of Probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial. J Endovasc Ther 11:595–604PubMedCrossRef

47.

Herrman JP, Hermans WR, Vos J, et al. (1993) Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the holy grail? Drugs 46:18–52PubMedCrossRef

48.

Boger RH, Bode-Boger SM, Alfke H (1996) Restenosis after percutaneous transluminal angioplasty. II. Possibilities for pharmacologic intervention. Vasa 25:21–31PubMed

49.

Russo R, Apostol J, Silva P, et al. (2000) Is intravascular ultrasound necessary for dose prescription during femoral artery brachytherapy? Observations from the Paris trial. Circulation 102(Suppl II):2065

50.

Wohlgemuth W, Bohndorf K (2003) Endovascular brachytherapy to prevent restenosis after angioplasty. Fortschr Röntgenstr 175:246–252CrossRef

51.

Kotzerke J, Rentschler M, Glatting G, et al. (1998) Dosimetry fundamentals of endovascular therapy using Re-188 for the prevention of restenosis after angioplasty. Nuklearmedizin 37:68–72PubMed

52.

Stabin MG, Konijnenberg M, Knapp FF Jr, et al. (2000) Monte Carlo modeling of radiation dose distributions in intravascular radiation therapy. Med Phys 27:1086–1092PubMedCrossRef

53.

Wuu C-S, Schiff P, Maryanski MJ, et al. (2003) Dosimetry study of Re-188 liquid balloon for intravascular brachytherapy using polymer gel dosimeters and laser-beam optical CT scanner. Med Phys 30:132–137PubMedCrossRef

54.

Kirisits C, Pokrajac B, Berger D, et al. (2004) Treatment parameters for beta and gamma devices in peripheral endovascular brachytherapy. Int J Radiat Oncol Biol Phys 60:1652–1659PubMedCrossRef

55.

Amols HI, Trichter F, Weinberger J (1998) Intracoronary radiation for prevention of restenosis. Dose pertubations caused by stents. Circulation 98:2024–2029PubMed

56.

Sureka CS, Sunny CS, Subbaiah KV, et al. (2007) Dose distribution for endovascular brachytherapy using Ir-192 sources: comparison of Monte Carlo calculations with radiochromic film measurements. Phys Med Biol 52:525–537PubMedCrossRef

57.

Dries WJF (1997) Monte Carlo calculated dose distribution for endovascular HDR brachytherapy with Ir-192. Radiother Oncol 45:77–82PubMedCrossRef

58.

Williamson JF, Li Z (1995) Monte Carlo aided dosimetry of the microselection pulsed and high dose-rate ¹⁹²Ir sources. Med Phys 22:809–819PubMedCrossRef

59.

Ye SJ, Ishmael PE, Feldmeier JJ (2003) Dosimetric caracteristics of a linear array of gamma or beta emitting seeds in intravascular irradiation: Monte Carlo studies for the AAPM TG-43/60 formalism. Med Phys 30:403–414PubMedCrossRef

60.

Baltas D, Karaiskos P, Papagiannis P, et al. (2001) Beta versus gamma dosimetry close to Ir-192 brachytherapy source. Med Phys 28:1875–1882PubMedCrossRef

61.

Xu XG (2005) Effective dose for patients undergoing coronary and femoral intravascular radiotherapy involving an HDR ¹⁹²Ir source. Radiat Prot Dosim 115:289–293CrossRef

62.

Amols HI, Reinstein LE, Weinberger J (1996) Dosimetry of radioactive coronary balloon dilatation catheter for treatment of neointimal hyperplasia. Med Phys 23:1793–1788CrossRef

63.

Popowsky Y, Verin V, Schwager M, et al. (1996) A novel system for intracoronary β-irradiation: description and dosimetric results. Int J Radiat Oncol Biol Phys 36:923–931CrossRef

64.

Kirisits C, Georg D, Wexberg P, et al. (2002) Determination and application of the reference isodose length (RIL) for commercial endovascular brachytherapy devices. Radiother Oncol 64:309–315PubMedCrossRef

65.

Albiero R, Nishida T, Adamian M, et al. (2000) Edge restenosis after implantation of high activity (³²)P radioactive beta-emitting stents. Circulation 101:2454–2457PubMed

66.

Hoher M, Wohrle J, Wohlfrom M, et al. (2000) Intracoronary beta-irradiation with a liquid (188)re-filled balloon: six-month results from a clinical safety and feasibility study. Circulation 101:2355–2360PubMed

67.

Sabate M, Serruys PW, van der Giessen WJ, et al. (1999) Geometric vascular remodeling after balloon angioplasty and beta-radiation therapy: a three-dimensional intravascular ultrasound study. Circulation 100:1182–1188PubMed

68.

Sabate M, Costa MA, Kozuma K, et al. (2000) Geographic miss: a cause of treatment failure in radio-oncology applied to intracoronary radiation therapy. Circulation 101:2467–2471PubMed

69.

Lansky AJ, Popma JJ, Massullo V, et al. (1999) Quantitative angiographic analysis of stent restenosis in the Scripps Coronary Radiation to Inhibit Intimal Proliferation Post Stenting (SCRIPPS) Trial. Am J Cardiol 84:410–414PubMedCrossRef

70.

Cheneau E, Waksman R, Yazdi H, et al. (2002) How to fix the edge effect of catheter-based radiation therapy in stented arteries. Circulation 106:2271–2277PubMedCrossRef

71.

Ahmed JM, Mintz GS, Waksman R, et al. (2000) Safety of intracoronary gamma-radiation on uninjured reference segments during the first 6 months after treatment of in-stent restenosis: a serial intravascular ultrasound study. Circulation 101:2227–2230PubMed

72.

Kollaard RP, Dries WJF, van Kleffens HJ, et al. (2006) Recommendations on detectors and quality control procedures for brachytherapy beta sources. Radither Oncol 78:223–229CrossRef

73.

NCS (Netherlands Commission on Radiation Dosimetry) (2004) Quality control of sealed beta sources on brachytherapy. Recommendations on detectors, measurement procedures and quality control of beta sources. Report 14. Available at: http://www.ncs-dos.org

74.

Wyttenbach R, Gallino A, Alerci M, et al. (2004) Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging. Circulation 110:1156–1161PubMedCrossRef

75.

Pokrajac B, Pötter R, Wolfram RM, et al. (2005) Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study. Radiother Oncol 74:3–9PubMedCrossRef

76.

Schopohl B, Leirmann D, Pohlit LJ, et al. (1996) Endovascular brachytherapy with ¹⁹²Ir source for avoidance of intimal hyperplasia after percutaneous transluminal angioplasty and stent implantation in peripheral vessels: 6 years of experience. J Radiat Oncol Biol Phys 36:835–840CrossRef

77.

Wolfram R, Pokrajak B, Ahmadi R, et al. (2001) Endovascular brachytherapy for prophylaxis against restenosis after long-segment femoropopliteal stenting: initial results. Radiology 220:724–729PubMedCrossRef

78.

Wolfram RM, Budinsky AC, Pokrajac B, et al. (2005) Vascular brachytherapy with ¹⁹²Ir after femoropopliteal stent implantation in high-risk patients: twelve-month follow-up results from the Vienna-5 trial. Radiology 236:343–351PubMedCrossRef

79.

Knapp FF Jr, Guhlke S, Beets AL, et al. (1999) Endovascular beta irradiation for prevention of restenosis using solution radioisotopes: pharmacologic and dosimetric properties of rhenium-188 compounds. Cardiovasc Radiat Med 1:86–97CrossRef

80.

Nori D (2000) Cardiovascular radiation therapy IV: principles of external radiation for vascular applications. Syllabus, Washington, DC, p 204

81.

Steidle B (1994) Preventive percutaneous radiation therapy to avoid hyperplasia of the intima after angioplasty combined with stent-implantation. Strahlenther Onkol 170:151–154PubMed

82.

Fritz P, Stein U, Hasslacher C, et al. (2004) External beam radiotherapy fails to prevent restenosis after iliac or femoropopliteal percutaneous transluminal angioplasty: results of a prospective randomised double-blind study. Int J Radiat Oncol Biol Phys 59:815–821PubMedCrossRef

83.

Krueger K, Bendel M, Zaehringer M, et al. (2006) Endovascular gamma irradiation for the prevention restenosis after angioplasty of femoropopliteal de novo stenoses. Eur Radiol 16:399–406PubMedCrossRef

84.

Hagenaars T, If AP, van Sambeek MR, et al. (2002) Gamma radiation induces positive vascular remodeling after balloon angioplasty: a prospective, randomized intravascular ultrasound scan study. J Vasc Surg 36:318–324PubMedCrossRef

85.

Costa MA, Sabaté M, van der Giessen WJ, et al. (1999) Late coronary occlusion after intra-coronary brachytherapy. Circulation 100:789–792PubMed

86.

Shimotakahara S, Mayberg MR (1994) Gamma irradiation inhibits neointimal hyperplasia in rats after arterial injury. Stroke 25:424–428PubMed

87.

Waksman R, Robinson KA, Crocker IR, et al. (1995) Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine: a possible role for radiation therapy in restenosis pervention. Circulation 91:1533–1539PubMed

88.

Waksman R, Robinson KA, Crocker IR, et al. (1995) Intracoronary low-dose beta-irradiation inhibits neointima formation after coronary artery balloon injury in the swine restenosis model. Circulation 92:3025–3031PubMed

89.

Verin V, Popowski Y, de Bruyne B, et al. (2001) Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. N Engl J Med 344:243–249PubMedCrossRef

Title: Endovascular Brachytherapy in the Femoropopliteal Segment Using 192Ir and 188Re
Authors: Walter A. Wohlgemuth
Giesbert Leissner
Hermann Wengenmair
Klaus Bohndorf
Klaus Kirchhof
Publication date: 01-07-2008
Publisher: Springer-Verlag
Published in: CardioVascular and Interventional Radiology / Issue 4/2008
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-007-9275-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Endovascular Brachytherapy in the Femoropopliteal Segment Using ¹⁹²Ir and ¹⁸⁸Re

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2008

Microballoon Occlusion Test to Predict Colonic Ischemia After Transcatheter Embolization of a Ruptured Aneurysm of the Middle Colic Artery

Reply to “A Word of Caution Before Killing Hypogastric Arteries”

Bronchial Artery Embolization in the Management of Pulmonary Parenchymal Endometriosis with Hemoptysis

Percutaneous Injection of Lidocaine Within the Carotid Body Area in Carotid Artery Stenting: An “Old-New” Technique

A New Ischemic Model Using a Radiofrequency Wire Electrode in a Rabbit Hindlimb

Retrievable Vena Cava Filters in Major Trauma Patients: Prevalence of Thrombus Within the Filter